These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday.The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million.Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.Merit Medical shares gained 4.4% to $87.00 in pre-market trading.These analysts made changes to their price targets on Merit Medical following earnings announcement.

BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $100 to $105.

Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $90 to $101.